The nNOS-p38MAPK pathway is mediated by NOS1AP during neuronal death

Journal of Neuroscience

Volumn 33, Issue 19, 2013, Pages 8185-8201

  Li, Li Li ^a   Ginet, Vanessa ^b   Liu, Xiaonan ^a   Vergun, Olga ^a   Tuittila, Minna ^a,c   Mathieu, Marc ^d   Bonny, Christophe ^d   Puyal, Julien ^b   Truttmann, Anita C ^b   Courtney, Michael J ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF TURKU   (Finland)

^d Xigen Pharma   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CALCIUM; GLUTAMATE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROPROTECTIVE AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE 1 ADAPTOR PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; EXCITOTOXICITY; GENE SILENCING; GENETIC TRANSFECTION; GRANULE CELL; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOBLOTTING; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPHYSIOLOGICAL RECRUITMENT; NEUROPROTECTION; NEWBORN DISEASE; NONHUMAN; PDZ DOMAIN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANOXIA; BRAIN; CALCIUM; CELL DEATH; CELLS, CULTURED; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; GREEN FLUORESCENT PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; L-LACTATE DEHYDROGENASE; N-METHYLASPARTATE; NERVE TISSUE PROTEINS; NEURONS; NITRIC OXIDE SYNTHASE TYPE I; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDES; PROTEIN CONFORMATION; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84877305973     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4578-12.2013     Document Type: Article

References (68)

1. Aarts M, Liu Y, Liu L, Besshoh S, Arundine M, Gurd JW, Wang YT, Salter MW, Tymianski M (2002) Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science 298:846-850. CrossRef Medline
2. Alderton WK, Cooper CE, Knowles RG (2001) Nitric oxide synthases:structure, function and inhibition. Biochem J 357:593-615. CrossRef Medline
3. Arking DE, Pfeufer A, Post W, Kao WH, Newton-Cheh C, Ikeda M, West K, Kashuk C, Akyol M, Perz S, Jalilzadeh S, Illig T, Gieger C, Guo CY, Larson MG, Wichmann HE, Marbán E, O'Donnell CJ, Hirschhorn JN, Kääb S, et al. (2006) A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 38:644-651. CrossRef Medline
4. Atochin DN, Clark J, Demchenko IT, Moskowitz MA, Huang PL (2003) Rapid cerebral ischemic preconditioning in mice deficient in endothelial and neuronal nitric oxide synthases. Stroke 34:1299-1303. CrossRef Medline
5. Becker ML, Aarnoudse AJ, Newton-Cheh C, Hofman A, Witteman JC, Uitterlinden AG, Visser LE, Stricker BH (2008) Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea. Pharmacogenet Genomics 18:591-597. CrossRef Medline
6. Björkblom B, Ostman N, Hongisto V, Komarovski V, Filén JJ, Nyman TA, Kallunki T, Courtney MJ, Coffey ET (2005) Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effector. J Neurosci 25:6350-6361. CrossRef Medline
7. Borsello T, Clarke PG, Hirt L, Vercelli A, Repici M, Schorderet DF, Bogousslavsky J, Bonny C (2003) A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat Med 9:1180-1186. CrossRef Medline
8. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH (1991) Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7:615-624. CrossRef Medline
9. Brzustowicz LM (2008) NOS1AP in schizophrenia. Curr Psychiatry Rep 10: 158-163. CrossRef Medline
10. Burette A, Zabel U, Weinberg RJ, Schmidt HH, Valtschanoff JG (2002) Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus. J Neurosci 22:8961-8970. Medline
11. Cao J, Semenova MM, Solovyan VT, Han J, Coffey ET, Courtney MJ (2004) Distinct requirements for p38alpha and c-Jun N-terminal kinase stressactivated protein kinases in different forms of apoptotic neuronal death. J Biol Chem 279:35903-35913. CrossRef Medline
12. Cao J, Viholainen JI, Dart C, Warwick HK, Leyland ML, Courtney MJ (2005) The PSD-95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death. J Cell Biol 168: 117-126. Medline
13. Christopherson KS, Hillier BJ, Lim WA, Bredt DS (1999) PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem 274:27467-27473. CrossRef Medline
14. Coffey ET, Smiciene G, Hongisto V, Cao J, Brecht S, Herdegen T, Courtney MJ (2002) c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons. J Neurosci 22:4335-4345. Medline
15. Courtney MJ, Coffey ET (1999) The mechanism of Ara-C-induced apoptosis of differentiating cerebellar granule neurons. Eur J Neurosci 11:1073-1084. CrossRef Medline
16. Courtney MJ, Lambert JJ, Nicholls DG (1990) The interactions between plasma membrane depolarization and glutamate receptor activation in the regulation of cytoplasmic free calcium in cultured cerebellar granule cells. J Neurosci 10:3873-3879. Medline
17. Cui H, Hayashi A, Sun HS, Belmares MP, Cobey C, Phan T, Schweizer J, Salter MW, Wang YT, Tasker RA, Garman D, Rabinowitz J, Lu PS, Tymianski M (2007) PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors. J Neurosci 27: 9901-9915. CrossRef Medline
18. Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL, Davis RJ (1997) A Cytoplasmic Inhibitor of the JNK Signal Transduction Pathway. Science 277:693-696. CrossRef Medline
19. Elias GM, Nicoll RA (2007) Synaptic trafficking of glutamate receptors by MAGUK scaffolding proteins. Trends Cell Biol 17:343-352. CrossRef Medline
20. Elias GM, Funke L, Stein V, Grant SG, Bredt DS, Nicoll RA (2006) Synapsespecific and developmentally regulated targeting of AMPA receptors by a family of MAGUK scaffolding proteins. Neuron 52:307-320. CrossRef Medline
21. Fang M, Jaffrey SR, Sawa A, Ye K, Luo X, Snyder SH (2000) Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron 28:183-193. CrossRef Medline
22. Ferriero DM, Holtzman DM, Black SM, Sheldon RA (1996) Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol Dis 3:64-71. CrossRef Medline
23. Florio SK, Loh C, Huang SM, Iwamaye AE, Kitto KF, Fowler KW, Treiberg JA, Hayflick JS, Walker JM, Fairbanks CA, Lai Y (2009) Disruption of nNOS-PSD-95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents. Br J Pharmacol 158: 494-506. CrossRef Medline
24. Follstaedt SC, Barber SA, Zink MC (2008) Mechanisms of minocyclineinduced suppression of simian immunodeficiency virus encephalitis: inhibition of apoptosis signal-regulating kinase 1. J Neurovirol 14:376-388. CrossRef Medline
25. Gardoni F, Mauceri D, Malinverno M, Polli F, Costa C, Tozzi A, Siliquini S, Picconi B, Cattabeni F, Calabresi P, Di Luca M (2009) Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depression. J Neurosci 29:669-677. CrossRef Medline
26. Ginet V, Puyal J, Magnin G, Clarke PG, Truttmann AC (2009) Limited role of the c-Jun N-terminal kinase pathway in a neonatal rat model of cerebral hypoxia-ischemia. J Neurochem 108:552-562. CrossRef Medline
27. Gladstone DJ, Black SE, Hakim AM; Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery (2002) Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33:2123-2136. CrossRef Medline
28. Greiner C, Schmidinger A, Hülsmann S, Moskopp D, Wölfer J, Köhling R, Speckmann EJ, Wassmann H (2000) Acute protective effect of nimodipine and dimethyl sulfoxide against hypoxic and ischemic damage in brain slices. Brain Res 887:316-322. CrossRef Medline
29. Hamada Y, Hayakawa T, Hattori HH., Mikawa H (1994) Inhibitor of nitric oxide synthesis reduces hypoxic-ischemic brain damage in the neonatal rat. Pediatr Res 35:10-14. CrossRef Medline
30. Harris BZ, Hillier BJ, Lim WA (2001) Energetic determinants of internal motif örecognition by PDZ domains. Biochemistry 40:5921-5930. CrossRef Medline
31. Hee Han B, Choi J, Holtzman DM (2002) Evidence that p38 mitogenactivated protein kinase contributes to neonatal hypoxic-ischemic brain injury. Dev Neurosci 24:405-410. CrossRef Medline
32. Hill MD, Martin RH, Mikulis D, Wong JH, Silver FL, Terbrugge KG, Milot G, Clark WM, Macdonald RL, Kelly ME, Boulton M, Fleetwood I, McDougall C, Gunnarsson T, Chow M, Lum C, Dodd R, Poublanc J, Krings T, Demchuk AM, et al. (2012) Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 11: 942-950. CrossRef Medline
33. Hillier BJ, Christopherson KS, Prehoda KE, Bredt DS, Lim WA (1999) Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. Science 284:812-815. CrossRef Medline
34. Hirt L, Badaut J, Thevenet J, Granziera C, Regli L, Maurer F, Bonny C, Bogousslavsky J (2004) D-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia. Stroke 35:1738-1743. CrossRef Medline
35. Hu SQ, Ye JS, Zong YY, Sun CC, Liu DH, Wu YP, Song T, Zhang GY (2012) S-nitrosylation of mixed lineage kinase 3 contributes to its activation after cerebral ischemia. J Biol Chem 287:2364-2377. CrossRef Medline
36. Iadecola C (1997) Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20:132-139. CrossRef Medline
37. Ishida A, Trescher WH, Lange MS, Johnston MV (2001) Prolonged suppression of brain nitric oxide synthase activity by 7-nitroindazole protects against cerebral hypoxic-ischemic injury in neonatal rat. Brain Dev 23: 349-354. CrossRef Medline
38. Ishii H, Shibuya K, Ohta Y, Mukai H, Uchino S, Takata N, Rose JA, Kawato S (2006) Enhancement of nitric oxide production by association of nitric oxide synthase with N-methyl-D-aspartate receptors via postsynaptic density 95 in genetically engineered Chinese hamster ovary cells: real-time fluorescence imaging using nitric oxide sensitive dye. J Neurochem 96: 1531-1539. CrossRef Medline
39. Jaffrey SR, Snowman AM, Eliasson MJ, Cohen NA, Snyder SH (1998) CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD-95. Neuron 20:115-124. CrossRef Medline
40. Kawasaki H, Morooka T, Shimohama S, Kimura J, Hirano T, Gotoh Y, Nishida E (1997) Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol Chem 272:18518-18521. CrossRef Medline
41. Keynes RG, Duport S, Garthwaite J (2004) Hippocampal neurons in organotypic slice culture are highly resistant to damage by endogenous and exogenous nitric oxide. Eur J Neurosci 19:1163-1173. CrossRef Medline
42. Kim E, Sheng M (2004) PDZ domain proteins of synapses. Nat Rev Neurosci 5:771-781. CrossRef Medline
43. Kojima H, Urano Y, Kikuchi K, Higuchi T, Hirata Y, Nagano T (1999) Fluorescent indicators for imaging nitric oxide production. Angew Chem Int Ed Engl 38:3209-3212. CrossRef Medline
44. Kuma Y, Sabio G, Bain J, Shpiro N, Márquez R, Cuenda A (2005) BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo. J Biol Chem 280: 19472-19479. CrossRef Medline
45. Langnaese K, Richter K, Smalla KH, Krauss M, Thomas U, Wolf G, Laube G (2007) Splice-isoform specific immunolocalization of neuronal nitric oxide synthase in mouse and rat brain reveals that the PDZ-complexbuilding nNOSalpha beta-finger is largely exposed to antibodies. Dev Neurobiol 67:422-437. CrossRef Medline
46. Lehtinen AB, Newton-Cheh C, Ziegler JT, Langefeld CD, Freedman BI, Daniel KR, Herrington DM, Bowden DW (2008) Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study. Diabetes 57:1108-1114. CrossRef Medline
47. Philippides A, Ott SR, Husbands P, Lovick TA, O'Shea M (2005) Modeling cooperative volume signaling in a plexus of nitric-oxide-synthaseexpressing neurons. J Neurosci 25:6520-6532. CrossRef Medline
48. Rice JE 3rd, Vannucci RC, Brierley JB (1981) The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9:131-141. CrossRef Medline
49. Samdani AF, Dawson TM, Dawson VL (1997) Nitric oxide synthase in models of focal ischemia. Stroke 28:1283-1288. CrossRef Medline
50. Savinainen A, Garcia EP, Dorow D, Marshall J, Liu YF (2001) Kainate receptor activation induces mixed lineage kinase-mediated cellular signaling cascades via post-synaptic density protein 95. J Biol Chem 276:11382-11386. CrossRef Medline
51. Schepens J, Cuppen E, Wieringa B, Hendriks W (1997) The neuronal nitric oxide synthase PDZ motif binds to -G(DE)XV* carboxyterminal sequences. FEBS Lett 409:53-56. CrossRef Medline
52. Semenova MM, Mäki-Hokkonen AM, Cao J, Komarovski V, Forsberg KM, Koistinaho M, Coffey ET, Courtney MJ (2007) Rho mediates calciumdependent activation of p38alpha and subsequent excitotoxic cell death. Nat Neurosci 10:436-443. Medline
53. Soriano FX, Martel MA, Papadia S, Vaslin A, Baxter P, Rickman C, Forder J, Tymianski M, Duncan R, Aarts M, Clarke P, Wyllie DJ, Hardingham GE (2008) Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand. J Neurosci 28:10696-10710. CrossRef Medline
54. Stricker NL, Christopherson KS, Yi BA, Schatz PA, Raab RW, Dawes G, Bassett DE, Bredt DS, Li M (1997) PDZ domain of neuronal nitric oxide synthase recognises novel C-terminal peptide sequences Nat Biotech 15: 336-342. CrossRef
55. Takahashi M, Gotoh Y, Isagawa T, Nishimura T, Goyama E, Kim HS, Mukai H, Ono Y (2003) Regulation of a mitogen-activated protein kinase kinase kinase, MLTK by PKN. J Biochem 133:181-187. CrossRef Medline
56. Tochio H, Zhang Q, Mandal P, Li M, Zhang M (1999) Solution structure of the extended neuronal nitric oxide synthase PDZ domain complexed with an associated peptide. Nat Struct Biol 6:417-421. CrossRef Medline
57. Tochio H, Mok YK, Zhang Q, Kan HM, Bredt DS, Zhang M (2000) Formation of nNOS/PSD-95 PDZ dimer requires a preformed beta-finger structure from the nNOS PDZ domain. J Mol Biol 303:359-370. CrossRef Medline
58. Valtschanoff JG, Weinberg RJ (2001) Laminar organization of the NMDA receptor complex within the postsynaptic density. J Neurosci 21:1211-1217. Medline
59. Vaslin A, Puyal J, Clarke PG (2009) Excitotoxicity-induced endocytosis confers drug targeting in cerebral ischemia. Ann Neurol 65:337-347. CrossRef Medline
60. Weiss SW, Albers DS, Iadarola MJ, Dawson TM, Dawson VL, Standaert DG (1998) NMDAR1 glutamate receptor subunit isoforms in neostriatal, neocortical, and hippocampal nitric oxide synthase neurons. J Neurosci 18:1725-1734. Medline
61. Wendland B, Schweizer FE, Ryan TA, Nakane M, Murad F, Scheller RH, Tsien RW (1994) Existence of nitric oxide synthase in rat hippocampal pyramidal cells. Proc Natl Acad Sci U S A 91:2151-2155. CrossRef Medline
62. Westerlund N, Zdrojewska J, Courtney MJ, Coffey ET (2008) Superior cervical ganglion-10 protein as a molecular effector of c-Jun N-terminal kinase 1: implications for the therapeutic targeting of Jun N-terminal kinase in nerve regeneration. Expert Opin Ther Targets 12:31-43. CrossRef Medline
63. Westerlund N, Zdrojewska J, Padzik A, Komulainen E, Björkblom B, Rannikko E, Tararuk T, Garcia-Frigola C, Sandholm J, Nguyen L, Kallunki T, Courtney MJ, Coffey ET (2011) Phosphorylation of SCG10/stathmin-2 determines multipolar stage exit and neuronal migration rate. Nat Neurosci 14:305-313. CrossRef Medline
64. Yang H, Courtney MJ, Martinsson P, Manahan-Vaughan D (2011) Hippocampal long-term depression is enhanced depotentiation is inhibitedandlong-term potentiation is unaffected by the application of a selective c-Jun N-terminal kinase inhibitor to freely behaving rats. Eur J Neurosci 33:1647-1655. CrossRef Medline
65. Yoshimura Y, Yamauchi Y, Shinkawa T, Taoka M, Donai H, Takahashi N, Isobe T, Yamauchi T (2004) Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography-tandem mass spectrometry. J Neurochem 88: 759-768. Medline
66. Zhang H, Zhang R, Luo Y, D'Alessio A, Pober JS, Min W (2004) AIP1/ DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2- induced ASK1-JNK activation. J Biol Chem 279:44955-44965. CrossRef Medline
67. Zhou L. Li F, Xu HB, Luo CX, Wu HY, Zhu MM, Lu W, Ji X, Zhou QG, Zhu DY (2010) Treatment of cerebral ischemia by disrupting ischemiainduced interaction of nNOS PSD-95. Nat Med 16:1439-1443. CrossRef Medline
68. Zhu C, Qiu L, Wang X, Hallin U, Candé C, Kroemer G, Hagberg H, Blomgren K (2003) Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain. J Neurochem 86:306-317. Medline